Among these, I148M PNPLA3 variant is recognized as the most common genetic determinant of NAFLD onset and progression towards Nonalcoholic steatohepatitis (NASH) fibrosis and even hepatocellular carcinoma (HCC) [19, 20]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.